Mauro Alaibac

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Basal Cell Carcinoma

Atopic Dermatitis

Top Venues

Patient preference and adherence

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Roberto Mazzetto, Alvise Sernicola, Paola Miceli, Jacopo Tartaglia, Christian Ciolfi, Mauro Alaibac
Anti-tumor immunity and vitiligo: from immune-related adverse reactions to protection from cancer. Immunotherapy (2024)
Amelia Ruffatti, Marta Tonello, Antonia Calligaro, Teresa Del Ross, Maria Favaro, Margherita Zen, Ariela Hoxha, Mauro Alaibac
Prevalence and adverse consequences of delayed diagnosis and misdiagnosis in thrombotic antiphospholipid syndrome. An observational cohort study and a review of the literature. Clinical rheumatology (2023)
Christian Ciolfi, Alvise Sernicola, Mauro Alaibac
Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability. Patient preference and adherence 16 (2022)
Martina Ferranti, Giulia Tadiotto Cicogna, Francesco Messina, Mauro Alaibac
Management of PD-1/PD-L1 blockade immune-related skin toxicities: perspectives and issues. Immunotherapy 13 (10) (2021)
Emiliano Antiga, Veronica Bonciolini, Simone Cazzaniga, Mauro Alaibac, Antonino Salvatore Calabrò, Carla Cardinali, Emanuele Cozzani, Angelo Valerio Marzano, Giuseppe Micali, Tarcisio Not, Pietro Quaglino, Camilla Vassallo, Luigi Naldi, Marzia Caproni, null The Gised Group And The Italian Group For Cutaneous Immunopathology
Female Patients with Dermatitis Herpetiformis Show a Reduced Diagnostic Delay and Have Higher Sensitivity Rates at Autoantibody Testing for Celiac Disease. BioMed research international 2019 (2019)
Giulia Tadiotto Cicogna, Francesco Messina, Linda Nalotto, Serena Szekely, Mauro Alaibac
Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy. F1000Research 8 (2019)
Irene Russo, Ludovica Zorzetto, Vanna Chiarion Sileni, Mauro Alaibac
Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma. Scientifica 2018 (2018)